07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
On 17 March 2020, the UAE Cabinet issued the complete Positive List for FDI in the UAE, enumerating ...
Read More >
As the summer begins to wind down, the first whispers of fall rippling through cool evening breezes ...
Read More >
Seeking to control healthcare costs, many group health plans have adopted amendments that lower reim...
Read More >
House and Senate members continued their work towards a budget deal ahead of the approaching end of ...
Read More >
On September 3, 2020, the Antitrust Division of the U.S. Department of Justice (the “Division”) is...
Read More >
Gables Construction, Inc. v. Red Coats, Inc., No. 23, 2020 BL 193791, 2020 MD LEXIS 264 (Md. May 26,...
Read More >